Skip to main content

Want a detailed portfolio tracker?

Vaxcyte (PCVX) P/E (2020 - 2026)

Vaxcyte (PCVX) P/E from Jun 30, 2020 to Jul 21, 2026. The TTM Vaxcyte (PCVX) P/E is -8.26. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Vaxcyte (PCVX)

YearP/EChange
2026-8.26+5.54%
2025-7.83-62.08%
2024-20.65+12.95%
2023-18.28+14.88%
2022-15.92+28.02%
2021-12.43-43.01%
2020-21.81N/A

Comparison Vaxcyte (PCVX) P/E with competitors

Vaxcyte (PCVX) P/E is -8.26.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.02%
NBYStablecoin Development Corp0.00-100.05%
ENLVEnlivex Ltd0.07-100.91%
FGENFibroGen Inc0.24-102.90%
CHRSCoherus Biosciences Inc0.85-110.27%
FBIOFortress Biotech Inc0.95-111.48%
ORMPOramed Pharmaceuticals Inc1.50-118.19%
AGENAgenus Inc3.01-136.41%
INVAInnoviva Inc3.15-138.16%
VXRTVaxart Inc3.55-142.95%
CRMDCorMedix Inc3.63-143.90%
CVACCureVac N.V.4.45-153.79%
GLPGGalapagos NV4.86-158.79%
SRPTSarepta Therapeutics Inc4.88-159.07%
ABEOAbeona Therapeutics Inc5.39-165.18%
ABUSArbutus Biopharma Corp5.60-167.70%
ZVRAZevra Therapeutics Inc5.89-171.23%
SPROSpero Therapeutics Inc6.23-175.36%
CGENCompugen Ltd6.31-176.39%
RIGLRigel Pharmaceuticals6.87-183.14%
SLXNSilexion Therapeutics Corp7.30-188.27%
OMEROmeros Corporation9.26-212.02%
AUPHAurinia Pharmaceuticals Inc9.58-215.97%
PLXProtalix BioTherapeutics Inc10.89-231.77%
ACADAcadia Pharmaceuticals Inc11.73-241.90%
TBPHTheravance Biopharma Inc12.26-248.36%
ADMAAdma Biologics Inc12.42-250.25%
HRMYHarmony Biosciences Holdings Inc13.82-267.21%
SABSSAB Biotherapeutics Inc14.14-271.03%
NAGENiagen Bioscience Inc14.82-279.28%
INCYIncyte Corp15.82-291.44%
REGNRegeneron Pharmaceuticals Inc15.86-291.85%
PBYIPuma Biotechnology Inc17.32-309.50%
CPRXCatalyst Pharmaceuticals Inc17.44-311.00%
EXELExelixis Inc17.54-312.19%
TGTXTG Therapeutics Inc18.97-329.47%
MDXGMimedx Group Inc20.55-348.66%
XOMAXOMA Royalty Corp22.87-376.77%
ARGXArgen X SE24.30-393.99%
CTMXCytomX Therapeutics Inc24.82-400.32%
XOMAOXOMA Royalty Corp25.34-406.65%
HALOHalozyme Therapeutics Inc25.62-410.03%
XOMAPXOMA Royalty Corp25.67-410.59%
VRTXVertex Pharmaceuticals Inc27.99-438.72%
RPRXRoyalty Pharma plc - Class A28.69-447.10%
SLNOSoleno Therapeutics Inc29.02-451.06%
ASNDAscendis Pharma A/S30.09-464.01%
LGNDLigand Pharmaceuticals Inc - Class B37.91-558.71%
APLSApellis Pharmaceuticals Inc39.02-572.13%
BMRNBiomarin Pharmaceutical Inc42.21-610.73%
KRYSKrystal Biotech Inc45.34-648.62%
ONCBeiGene Ltd69.54-941.39%
PHARPharming Group N.V.75.03-1007.76%
TECHBio-Techne Corp101.96-1333.62%
VCELVericel Corp109.92-1429.97%
ALNYAlnylam Pharmaceuticals Inc117.96-1527.29%
GMABGenmab140.29-1797.42%
TLXTelix Pharmaceuticals Ltd162.15-2061.94%
CORTCorcept Therapeutics Inc212.86-2675.43%